Immune System Key Ltd
Immune System Key Ltd
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| NEROFE and Doxorubicin in KRAS-mutated ST2-positive Solid Tumors | KRAS Mutation-Related Tumors; Solid Tumor | Recruiting | Phase 1 | 2026-03-06 | NCT05661201 |